drugset / Trial / NCT06293989

Efficacy and Safety of Intravenous Diazepam Given at 2 Different Doses Compared to Placebo in Acute Peripheral Vertigo

NCT06293989

Phase 3 Unknown 1000 enrolled University of Monastir
RandomizedParallel-groupSingle-blindTreatment

Summary

This is prospective, randomised double-blind study that will be conducted in the emergency department of 3 university hospitals (FB Monastir, Sahloul Sousse, and FH Sousse) to compare the efficacy of two doses of diazepam (Valium®) and placebo for the relief of acute periphery vertigo in the ED

Timeline

Start
2024-05-01
Primary completion
2025-12-30
Completion
2026-03-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Diazepam Small molecule 5 mg Intravenous
Subject Diazepam Small molecule 10 mg Intravenous

Indications